Content Warning: This post contains my candid thoughts about my experience taking Ozempic and Mounjaro, two GLP-1 receptor agonists
For many patients seeking both glycemic control and significant weight loss, Ozempic emerges as the stronger option
BMC Endocrine Disorders , 23 (1), 245
Blood Donor Room 212-639-7643 Call for information if youre interested in donating blood or platelets
Chromium picolinate forms when chromium combines with picolinic acid
In a new systematic review of existing research, led by professor Clare Collins of the Newcastle School of Health Sciences in New South Wales, Australia, it appears that very few global trials of the drugs have taken into consideration what and how much patients are eating while using them